Louise Faaborg

Palle Juul Jensens Boulevard 99
Arhus, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Bevacizumab and Tocotrienol in Recurrent Platinum-Resistant Ovarian Cancer, and the Role of HOXA9 as a Prognostic Biomarker.

Bevacizumab and Tocotrienol in Recurrent Platinum-Resistant Ovarian Cancer, and the Role of HOXA9 as a Prognostic Biomarker.

Journal: Diseases (Basel, Switzerland)

Published: December 17, 2025

Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer.

Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer.

Journal: Future oncology (London, England)

Published: November 15, 2023

Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer.

Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer.

Journal: Cancers

Published: March 03, 2022

Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia.

Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia.

Journal: Cancers

Published: January 04, 2022

HOXA9-methylated DNA as a diagnostic biomarker of ovarian malignancy.

HOXA9-methylated DNA as a diagnostic biomarker of ovarian malignancy.

Journal: Biomarkers in medicine

Published: September 13, 2021

Analysis of HOXA9 methylated ctDNA in ovarian cancer using sense-antisense measurement.

Analysis of HOXA9 methylated ctDNA in ovarian cancer using sense-antisense measurement.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: July 06, 2021

Early ctDNA response to chemotherapy. A potential surrogate marker for overall survival.

Early ctDNA response to chemotherapy. A potential surrogate marker for overall survival.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 18, 2021

Measurement of dabigatran: previously demonstrated Hemoclot® Thrombin Inhibitor assay reagent instability on Sysmex CS-2100i is no longer an issue.

Measurement of dabigatran: previously demonstrated Hemoclot® Thrombin Inhibitor assay reagent instability on Sysmex CS-2100i is no longer an issue.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: November 17, 2017

Triploidy--Observations in 154 Diandric Cases.

Triploidy--Observations in 154 Diandric Cases.

Journal: PloS one

Published: August 01, 2015

A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group.

A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 25, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026